Reports covering Cypress Exchange Properties and the CXP Orthopedic Surgery Center DST are now available through the FactRight Report Center.
RANCHO SANTA MARGARITA , CA, UNITED STATES, August 18, 2026 /EINPresswire.com/ — Cypress Exchange Properties, LLC (“CXP”) announced today that FactRight has completed and published independent due-diligence reports covering CXP as a sponsor and its most recent Delaware Statutory Trust offering, the CXP Orthopedic Surgery Center DST.
The reports are now available for eligible financial professionals to access and download through the FactRight Report Center – www.factright.com or www.factrightreportcenter.com.
The CXP Orthopedic Surgery Center DST is a Rule 506(c) offering with a $50,000 minimum investment. The offering is structured for accredited investors, including eligible investors seeking to complete a tax-deferred exchange under Section 1031 of the Internal Revenue Code. Securities related to the offering are being offered through Emerson Equity LLC, Member FINRA/SIPC, which is not affiliated with Cypress Exchange Properties.
FactRight is a leading provider of independent due-diligence and risk-management services for the alternative-investment industry. The firm provides research and analysis to registered investment advisers, broker-dealers, family offices and other wealth-management professionals evaluating alternative-investment sponsors and offerings.
FactRight’ s due-diligence process includes an extensive review of a sponsor’s management team, organizational structure, operating history, financial condition, internal controls and operational capabilities. Its offering-level analysis evaluates the investment structure, underlying real estate, financing, fees, assumptions, potential risks and other material terms of the offering.
“We are pleased to have completed FactRight’ s comprehensive review process and to make these reports available to financial professionals evaluating Cypress Exchange Properties and the CXP Orthopedic Surgery Center DST,” said Christopher Cumella, President and CEO of Cypress Exchange Properties. “Transparency, disciplined underwriting and strong operating practices are central to our business. These reports provide advisers and their due-diligence teams with an independent resource for evaluating our company and this offering.”
Eligible financial professionals may access the reports by logging into the FactRight Report Center
and searching for Cypress Exchange Properties or CXP Orthopedic Surgery Center DST.
Additional information regarding the offering is available at www.cypressxp.com. Interested investors and financial professionals may also contact the Cypress Exchange Properties team directly at info@cypressxp.com.
About Cypress Exchange Properties
Cypress Exchange Properties is a real estate investment sponsor focused on structuring Delaware Statutory Trust offerings for accredited investors. CXP seeks to provide access to institutional-quality real estate investments and potential Section 1031 exchange solutions through disciplined underwriting, experienced asset management and transparent communication.
This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase securities. Any offering is made solely through the applicable private placement memorandum and related offering documents. Securities are offered through Emerson Equity LLC, member FINRA/SIPC. Cypress Exchange Properties and Emerson Equity LLC are separate and unaffiliated entities. Investments involve risk, including the possible loss of principal. The publication of a third-party due-diligence report should not be interpreted as an endorsement, investment recommendation or guarantee of investment performance.
# # #
jessica spaulding
The Spaulding Agency
email us here
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
